News for BeiGene Ltd (spons. ADRs)

Seeking Alpha 686d

BeiGene beats top and bottom line Q2 estimates

Seeking Alpha 687d

Notable earnings before Wednesday's open

Markets Insider Automation 687d

BeiGene earnings preview: what Wall Street is expecting

Benzinga 694d

Growing Competition in Hematology, Aesthetics Complicates AbbVie's Post-Humira Landscape, Analyst Says

Seeking Alpha 698d

BeiGene drug gets positive EMA panel opinion for esophageal cancer

TipRanks 700d

Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and BeiGene (BGNE)

Benzinga 702d

BeiGene's Brukinsa Positioned as Preferred BTK Inhibitor: Analyst Says Survey Supports Bullish View

Benzinga 702d

Benzinga's Top Ratings Upgrades, Downgrades For July 17, 2023

TipRanks 702d

Citi Reaffirms Their Buy Rating on BeiGene (BGNE)

Seeking Alpha 705d

Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown

Seeking Alpha 707d

BeiGene wins FDA review to expand Brukinsa label for lymphoma

TipRanks 707d

BeiGene (BGNE) Receives a Hold from Bank of America Securities

Seeking Alpha 708d

Novartis ends licensing deal with BeiGene

PR Newswire 719d

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages BeiGene, Ltd. Investors to Inquire About Securities Class Action Investigation - BGNE

Benzinga 719d

Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023

Benzinga 719d

Why This BeiGene Analyst Slashes Forecast By Almost 42%

Benzinga 719d

NVIDIA To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Friday

TipRanks 719d

Bernstein Sticks to Its Hold Rating for BeiGene (BGNE)

TipRanks 721d

Analysts Offer Insights on Healthcare Companies: Amedisys (AMED), Structure Therapeutics, Inc. Sponsored ADR (GPCR) and BeiGene (BGNE)

PR Newswire 726d

BGNE LOSS ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BeiGene, Ltd. Investors to Inquire About Securities Class Action Investigation - BGNE

Benzinga 734d

Why MicroVision Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket

Benzinga 734d

Gambling.com, Editas Medicine And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Seeking Alpha 734d

BTBT, GREE and CIFR among pre-market losers

Seeking Alpha 734d

AbbVie files patent lawsuit over BeiGene’s cancer drug - Bloomberg

Seeking Alpha 734d

Biggest stock movers today: MicroVision, BeiGene and more

TipRanks 735d

Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR) and BeiGene (BGNE)

TipRanks 763d

Bank of America Securities Reaffirms Their Hold Rating on BeiGene (BGNE)

TipRanks 771d

SVB Securities Remains a Buy on BeiGene (BGNE)

TipRanks 775d

Bernstein Sticks to Its Buy Rating for BeiGene (BGNE)

Seeking Alpha 776d

BeiGene Non-GAAP EPS of -$3.34 beats by $0.32, revenue of $447.8M misses by $1.64M

Seeking Alpha 777d

Immix stock slumps ~20% amid interim data for IMX-110 in colorectal cancer

Seeking Alpha 784d

Zymeworks, Jazz in pact over cancer antibody zanidatamab

Seeking Alpha 790d

Novartis, BeiGene tislelizumab meets main goal in gastric/esophagus cancer trial

InvestorPlace 791d

7 Biotech Stocks That Could Cure Your Portfolio Woes

TipRanks 798d

Analysts Offer Insights on Healthcare Companies: BeiGene (BGNE), Zynex (ZYXI) and Legend Biotech (LEGN)

Seeking Alpha 801d

Premier cancer research event, AACR is starting this week; Here is what to expect

TipRanks 816d

J.P. Morgan Analysts Say These 2 Stocks Are Their Top Picks for 2023

TipRanks 817d

5 Best Healthcare Stocks to Invest in Now, According to Analysts

Seeking Alpha 820d

Zymeworks a buy at Wells Fargo on royalty streams, future milestones

TipRanks 840d

Analysts Offer Insights on Healthcare Companies: BeiGene (BGNE), Arcus Biosciences (RCUS) and Karuna Therapeutics (KRTX)

TipRanks 840d

SVB Securities Sticks to Their Buy Rating for BeiGene (BGNE)

TipRanks 841d

Guggenheim Keeps Their Buy Rating on BeiGene (BGNE)

TipRanks 841d

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (ACAD), Henry Schein (HSIC) and BeiGene (BGNE)

Benzinga 842d

Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk

Seeking Alpha 842d

BeiGene GAAP EPADS of -$4.29 misses by $0.10, revenue of $380.1M misses by $8.07M

Seeking Alpha 845d

BeiGene Q4 2022 Earnings Preview

Seeking Alpha 863d

Quebec to fund BeiGene's Brukinsa to treat rare blood cancer

Seeking Alpha 867d

Roche CEO drags Arcus, iTeos lower after comments on cancer trial

TipRanks 876d

Morgan Stanley Reaffirms Their Buy Rating on BeiGene (BGNE)

Benzinga 880d

4 Analysts Have This to Say About BeiGene

	
		OSZAR »